Director, Global Merchandising SamsoniteDirector, Global MerchandisingMansfield, MAThis leader partners closely with regional merchandising teams, Global Marketing & Ecommerce (GMEO), Product Management, Planning, Sourcing, and Visual Merchandising to ensure cohesive assortments, disciplined SKU governance, and a strong omnichannel brand experience across full-price retail, outlet, and ecommerce channels. Reporting to the Vice President, Global Product & Brand Strategy, this role is responsible for executing the VP's vision on global product, brand, and lifecycle strategies into actionable merchandising and assortment frameworks that drive brand consistency, commercial performance, and operational efficiency worldwide.
Director, Intellectual Property DecipheraDirector, Intellectual PropertyWaltham, MA$218,000–$300,000 / yearROMVIMZA (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. In addition to advancing multiple product candidates from Deciphera's platform in clinical studies, QINLOCK (ripretinib) is Deciphera's switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Senior Director, Human Resources Business Partner Beam TherapeuticsSenior Director, Human Resources Business PartnerCambridge, MA$260,000–$320,000 / yearThe Senior Director, Human Resources Business Partner (HRBP) serves as a strategic partner to leaders across the organization, providing guidance and support across a broad range of human resources functions, including employee relations, performance management, organizational design, workforce planning, and talent development. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Director of Administration and Finance Massachusetts Institute of TechnologyDirector of Administration and FinanceCambridge, MADIRECTOR OF ADMINISTRATION & FINANCE, Office of the Vice President for Energy and Climate (VPEC), will oversee all administrative and financial operations of the VPEC, including Climate, to ensure the office operates efficiently and effectively. The Director will provide strategic leadership, financial expertise, and operational guidance to support the VPEC's mission and objectives.
Executive Director, Philanthropy, BID Needham Hospital Beth Israel Lahey HealthExecutive Director, Philanthropy, BID Needham HospitalNeedham, MassachusettsAs member of the Community Hospital Division, the ED will help develop, articulate, and execute the strategic direction of the major gifts program, with a particular focus on securing six- and seven-figure commitments from individuals, to meet the current and future needs of the organization. May also be responsible for defining fundraising projects and/or priority clinical or specialty areas that may include working closely with Prospect Development team to develop pipelines from which to seek and secure philanthropic support.
Executive Director, Planned Giving-Philanthropy Beth Israel Lahey HealthExecutive Director, Planned Giving-PhilanthropyBoston, MassachusettsServes as a member of the BILH Philanthropy Senior Leadership Team with responsibility for advancing the system and affiliate institutions mission by working to identify, cultivate, solicit, steward, and retain planned gift ($100,000+) prospects and donors. Reporting to the Assistant Vice President, Philanthropy BIDMC of Beth Israel Lahey Health, and coordinating with the key others, the Executive Director of Planned Giving for BILH will lead a system-wide planned giving program across BILH business units.
Senior Director, Analytical Research & Development Third Rock Ventures LLCSenior Director, Analytical Research & DevelopmentBoston, MA$230,000–$270,000 / yearProvide technical leadership for analytical method development, validation, and transfer for DS and DP, utilizing techniques including (but not limited to) HPLC-CAD, HPLC-UV, GC, LC-MS, LC‑MS/MS, HPLC-FLR, LC-qToF, GC (Residual Solvents), Elemental impurity analysis, IR, qNMR, thermal analysis, droplet size, PSD, lipolysis, and dissolution/ drug release. The Senior Director, Analytical R&D, reports to the Vice President, CMC and is responsible for providing strategic and technical leadership for analytical development of small molecules within Seaport's portfolio, from pre-clinical development to late-stage clinical development.
Executive Director, Philanthropy, BID Needham Hospital Lahey Hospital and Medical CenterExecutive Director, Philanthropy, BID Needham HospitalNeedham, MA$149,989–$215,000 / yearAs member of the Community Hospital Division, the ED will help develop, articulate, and execute the strategic direction of the major gifts program, with a particular focus on securing six- and seven-figure commitments from individuals, to meet the current and future needs of the organization. May also be responsible for defining fundraising projects and/or priority clinical or specialty areas that may include working closely with Prospect Development team to develop pipelines from which to seek and secure philanthropic support.
Director/Sr Director Biostatistics Aura BioSearchDirector/Sr Director BiostatisticsBoston, MassachusettsIn this role, reporting to the Vice President of Biometrics, you will work with cross-functional clinical teams overseeing statistical activities across clinical programs, including managing statistical deliverables outsourced to CROs. Provide strategic input for trial designs in early-phase and late-phase studies.
Director of Safety and Security MA Admin Vinfen CorpDirector of Safety and Security MA AdminCambridge, MA$100,000–$130,000 / yearTypical Requirements: • Seven to ten years of progressive leadership experience in safety and security, including at least five years in healthcare, behavioral health or human services settings • Demonstrated experience in enterprise security program development, risk assessment, workplace violence prevention and vendor management • Experience managing multi-site security vendor contracts and security technology implementations. Knowledge and Skills: • Ability to interpret and implement CARF and State funder requirements • Enterprise program leadership • Data-driven decision making • Crisis management • Strong alignment with person-centered service environments • Excellent organizational, time management, attention to detail and problem-solving skills • Ability to manage and function effectively as part of a multi-disciplinary team.
NewSenior Director, GMP Quality Generate Biomedicines IncSenior Director, GMP QualitySomerville, MA$210,000–$290,000 / yearThe Role: The Senior Director, GMP Quality will build/support and maintain fit-for-purpose quality systems, provide independent quality oversight of contract development and manufacturing organizations (CDMOs), contract testing laboratories, and other strategic partners, and ensure the company's products and processes meet applicable regulatory, GxP, and company requirements. Serve as an enterprise Quality leader and strategic advisor to Technical Operations, Regulatory Affairs, Supply Chain, executive leadership, and cross-functional teams on product quality, supply continuity, regulatory readiness, and business objectives.
Director, Global Corporate Communications, HR and Culture Communications Boston Scientific CorpDirector, Global Corporate Communications, HR and Culture CommunicationsMarlborough, MAServe as the senior communications advisor to the Chief Human Resources Officer (CHRO) and HR Leadership Team (HRLT), providing strategic counsel on enterprise communications, organizational priorities, business transformation, organizational transformation, workforce issues and other high-impact or sensitive matters. In partnership with HR, corporate communications and business leaders, this role sets the strategic direction for HR communications, leads and develops a high-performing team, and drives measurable impact through clear, compelling and integrated communications that further strengthen culture, support business transformation and enhance the employee experience.
Senior Director, Analytical Development Generate Biomedicines IncSenior Director, Analytical DevelopmentSomerville, MA$210,000–$300,000 / yearReporting to the Vice President, Technical Operations, this leader will shape the future analytical operating model for Generate's biologics portfolio, including analytical strategy, method lifecycle management, release and stability testing, specifications, comparability, external analytical operations, GMP readiness, and commercialization preparation across CDMO and contract testing partners. The Senior Director will serve as the senior analytical partner to CMC, Process Development, MS&T, Quality, Regulatory, Supply Chain, and external partners, ensuring protein therapeutics are supported by phase-appropriate, scientifically rigorous, inspection-ready analytical control strategies that advance key company objectives and enable late-stage development and commercialization readiness.
Director, Intellectual Property Deciphera Pharmaceuticals IncDirector, Intellectual PropertyWaltham, MA$218,000–$300,000 / yearROMVIMZA (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. In addition to advancing multiple product candidates from Deciphera's platform in clinical studies, QINLOCK (ripretinib) is Deciphera's switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Vice President of Business Development (PepiX) XtalPi IncVice President of Business Development (PepiX)Somerville, MARole overview: You will make global BD strategy and run execution, build a high‑quality partner pipeline (MNC, mid‑biotech, regional pharma), lead term‑sheet negotiation for platform/pipeline deals, and establish post‑deal alliance governance. Market insight & opportunity mapping: Proactively monitor and analyze market dynamics, industry trends, competitive landscapes, and regulatory developments in biopharmaceutical sectors.
Senior Vice President, Clinical Development Kailera TherapeuticsSenior Vice President, Clinical DevelopmentWaltham, MassachusettsDesign, execute, complete, and communicate clinical trials (eg, scientific advisory boards, protocol development, regulatory and ethic committee interactions, medical monitoring, data analyses, study reports, regulatory correspondences and filings, presentations, and data dissemination). Remote employees must adhere to the Hub & Home working model, including a minimum of one week per month in the Waltham, MA corporate office (in addition to any other work-related travel), with overall work-related travel estimated at least 25%.
Vice President, Investor Relations Fiera Capital Private WealthVice President, Investor RelationsBoston, MAThis mid-level role is responsible for managing and strengthening relationships with existing investors (LPs), supporting fundraising efforts, producing high-quality marketing materials, investor reporting, communications, supporting new client onboarding, and serving as a key point of contact between the investment team and the investor base. In this role, the investor relations person will be exposed to different functional teams and liaison with various departments, including Real Estate Investment Team, Business Development, Marketing & RFP, Client & Account Servicing, Legal & Compliance, Operations & Finance, 3rd Party Vendors/Administrators.
Director, Asset Management Center of Excellence Ryder System IncDirector, Asset Management Center of ExcellenceProvidence, RIThe Director serves as the bridge between Asset Management, Finance, Pricing, Sales, Marketing, Operations, Technology, and Data Science, ensuring data-driven decisions improve revenue growth, profitability, asset utilization, customer value, and EBITDA performance. Compensation Information: The compensation offered to a candidate may be influenced by a variety of factors, including the candidate's relevant experience; education, including relevant degrees or certifications; work location; market data/ranges; internal equity; internal salary ranges; etc.
Associate Director, Post-Award Services, Sponsored Programs Boston UniversityAssociate Director, Post-Award Services, Sponsored ProgramsBoston, MA$120,375–$135,000Full timeReporting to the Assistant Vice President, Sponsored Programs, the Associate Director (AD), Sponsored Programs, Post-Award, is responsible for developing and managing a team who oversees the financial review and reporting services for Sponsored research at Boston University. This includes leveraging AI-supported analytics, predictive models, and automated quality-assurance tools to monitor trends, assess risk, and inform decision-making.
Executive Director, Clinical Development CRISPR Therapeutics AGExecutive Director, Clinical DevelopmentSouth Boston, MA$290,000–$315,000 / yearThe Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY (exagamglogene autotemcel [exa-cel]), the world's first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. Reporting to the Vice President of Clinical Development, the Executive Director will provide clinical development strategy, mentoring of clinical development leads, medical monitoring and clinical and scientific input to all stages of zugocaptagene-geleucel clinical development autoimmune programs.